215 related articles for article (PubMed ID: 23608451)
1. What's new in prognostication of melanoma in the dermatopathology laboratory?
Bangash HK; Romegialli A; Dadras SS
Clin Dermatol; 2013; 31(3):317-23. PubMed ID: 23608451
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
3. A proposal for improving multicolor FISH sensitivity in the diagnosis of malignant melanoma using new combined criteria.
Kerl K; Palmedo G; Wiesner T; Mentzel T; Rütten A; Schärer L; Paredes B; Hantschke M; Kutzner H
Am J Dermatopathol; 2012 Aug; 34(6):580-5. PubMed ID: 22668575
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
Senetta R; Paglierani M; Massi D
Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
[TBL] [Abstract][Full Text] [Related]
5. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
[TBL] [Abstract][Full Text] [Related]
6. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
Gammon B; Beilfuss B; Guitart J; Gerami P
Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
[TBL] [Abstract][Full Text] [Related]
7. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.
Clemente C; Bettio D; Venci A; Scopsi L; Rao S; Ferrari A; Piris A; Mihm MC
Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status.
Fang Y; Dusza S; Jhanwar S; Busam KJ
Int J Surg Pathol; 2012 Oct; 20(5):434-40. PubMed ID: 22561674
[TBL] [Abstract][Full Text] [Related]
9. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
Zembowicz A; Yang SE; Kafanas A; Lyle SR
Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.
Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P
Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization for ambiguous melanocytic tumors.
Gammon B; Gerami P
Histol Histopathol; 2012 Dec; 27(12):1539-42. PubMed ID: 23059884
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases.
North JP; Garrido MC; Kolaitis NA; LeBoit PE; McCalmont TH; Bastian BC
Am J Surg Pathol; 2014 Jun; 38(6):824-31. PubMed ID: 24618603
[TBL] [Abstract][Full Text] [Related]
14. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens.
Abásolo A; Vargas MT; Ríos-Martín JJ; Trigo I; Arjona A; González-Cámpora R
Clin Exp Dermatol; 2012 Dec; 37(8):838-43. PubMed ID: 22731835
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
[TBL] [Abstract][Full Text] [Related]
16. FISH analysis for diagnostic evaluation of challenging melanocytic lesions.
Zimmermann AK; Hirschmann A; Pfeiffer D; Paredes BE; Diebold J
Histol Histopathol; 2010 Sep; 25(9):1139-47. PubMed ID: 20607656
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.
Gerami P; Geraminegad P
G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.
Hossain D; Qian J; Adupe J; Drewnowska K; Bostwick DG
Melanoma Res; 2011 Oct; 21(5):426-30. PubMed ID: 21900793
[TBL] [Abstract][Full Text] [Related]
19. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.
Gerami P; Mafee M; Lurtsbarapa T; Guitart J; Haghighat Z; Newman M
Arch Dermatol; 2010 Mar; 146(3):273-8. PubMed ID: 20231497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]